Search results
AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
- Contact Us
If you have questions about a specific medical condition,...
- Medicines
In some cases, health care professionals and patients can...
- Our Company
We are a global, science-led, patient-focused pharmaceutical...
- Pipeline
Pipeline - AstraZeneca - Research-Based BioPharmaceutical...
- Our Therapy Areas
CVRM (Cardiovascular, Renal and Metabolism) is one of our...
- R&D
R&D - AstraZeneca - Research-Based BioPharmaceutical Company
- Media
Media - AstraZeneca - Research-Based BioPharmaceutical...
- Sustainability
Sustainability - AstraZeneca - Research-Based...
- Partnering
Joint research centres with leading academic institutes...
- Contact Us
Mar 22, 2021 · Reuters. Results from the long-awaited US trial of the Oxford-AstraZeneca Covid vaccine are out and confirm that the shot is both safe and highly effective. More than 32,000 volunteers took...
The Oxford–AstraZeneca COVID‑19 vaccine, sold under the brand names Covishield [31] and Vaxzevria [1] [32] among others, is a viral vector vaccine for the prevention of COVID-19. It was developed in the United Kingdom by Oxford University and British-Swedish company AstraZeneca, [33] [34] [35] using as a vector the modified chimpanzee ...
- AU: B1
- SARS-CoV-2
- Vaxzevria, Covishield
- Viral vector
People also ask
What does AstraZeneca do?
Is AstraZeneca a biopharmaceutical company?
Where is AstraZeneca based?
What makes AstraZeneca a sustainable company?
Jun 3, 2021 · The AstraZeneca vaccine Vaxzevria is a vaccine against COVID-19. It's not yet approved for use in the United States. We explain how it works and more.
The Oxford-AstraZeneca vaccine for Covid-19 is more rugged than the mRNA vaccines from Pfizer and Moderna. DNA is not as fragile as RNA, and the adenovirus’s tough protein coat helps protect...